Dynavax stock: buy or sell?
May 22nd, 2020
Dynavax Technologies Corporation, a clinical-stage immunotherapy company, focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation.
Should I buy Dynavax stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best time to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Dynavax Technologies stock situation right now, hence this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Dynavax stock a buy?
Financial institutions and banks post stock ratings everyday.Unfortunately, we couldn't detect any rating for DVAX stock for the last month.
Dynavax stock analysis
Dynavax Technologies shares plunged -9.36% to $5.13 on May/22.
Dynavax plunged a spooky -9.36% and closed at $5.13. In the last 6 days when DVAX stock price broke up the SMA200d line, it gained $0.58 (12.75%). From a daily perspective, DVAX is in a short term uptrend after plotting its last bottom ($3.55, on May/13) higher than the previous bottom, and its last top ($7.15, on Tuesday) also over the previous top. Now trading in between its last bottom and last top DVAX might consolidate in a plain range, waiting to break out over $7.15 or down under $3.55.
Dynavax shares crossed up the simple moving average line of 200d, closing at $5.13. With this, it's been 5 green weeks in a row, gaining $1.73 or 58.84%. Early April DVAX plunged a scary -7.82% in just one week.
Dynavax stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies.
Dynavax stock price history
Dynavax stock went public on February 19th, 2004 with a price of $83.001. Since then, DVAX stock lost a -93.80%, with a yearly average of -5.90%.
1: Adjusted price after possible price splits or reverse-splits.
Dynavax stock historical price chart
DVAX stock reached 52-week highs on December at $7.20, and all-time highs 2006-11-29 with a price of 106.6.
Dynavax stock price targetNobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we have not detected any price forecast for Dynavax Technologies stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareDynavax Technologies reported fine results for 2018-Q4 . Dynavax Technologies inched Earnings per Share (EPS) by 6.70%, beating experts of $-0.60. Dynavax Technologies posted $-0.64.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Dynavax annual revenues rocketed a super good 2,407.03% to $8.20 million USD from $0.33 marked in 2017. When comparing 2018 vs 2017, likewise, profit margin (that is, the net income divided by revenues) skyrocketed a 27,160.82% to -1,938.27%.
|2013||$11 M||-||$-66.72 M-593.1%||-|
|2014||$11 M||-1.94%||$-90.72 M-822.4%||35.97%|
|2015||$4.05 M||-63.29%||$-106.79 M-2636.9%||17.72%|
|2016||$11 M||172.67%||$-112.44 M-1018.2%||5.29%|
|2017||$0.33 M||-97.04%||$-95.15 M-29099.1%||-15.38%|
|2018||$8.20 M||2,407.03%||$-158.90 M-1938.3%||66.99%|
Quarterly financial resultsDynavax reported $5.32 M in sales for 2018-Q4, a 264.00% up compared to previous quarter. Reported quarter earnings marked $-39.97 M with a profit margin of -751.58%. Profit margin climbed a 2,022.41% compared to previous quarter when profit margin was -2,773.99%. When comparing revenues to same quarter last year, Dynavax Technologies sales marked an amazing gain and boosted a 25,223.81%. Looking back to recent quarterly results, Dynavax posted 4 positive quarters in a row.
|2017-Q1||$0.15 M||-||$-25.29 M-17087.8%||-|
|2017-Q2||$0.11 M||-29.05%||$-20.32 M-19352.4%||-19.65%|
|2017-Q3||$0.05 M||-49.52%||$-22.13 M-41750.9%||8.90%|
|2017-Q4||$0.02 M||-60.38%||$-27.42 M-130576.2%||23.92%|
|2018-Q1||$0.17 M||685.71%||$-38.96 M-23610.9%||42.07%|
|2018-Q2||$1.25 M||660.00%||$-39.44 M-3145.5%||1.25%|
|2018-Q3||$1.46 M||16.51%||$-40.53 M-2774.0%||2.75%|
|2018-Q4||$5.32 M||264.00%||$-39.97 M-751.6%||-1.38%|
Dynavax ownershipReviewing Dynavax Technologies ownership structure gives valuable information about the company and its governance (insider ownership) or the amount of investors that are on the short side.
Dynavax shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 1.15% of all shares.
In case of Dynavax stock, 73.91% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for DVAX stock account 0.00%, no big difference from last month.
For a better context understanding, the following table shows ownership data compared to other related companies:
|Market cap||$472.9 M|
|Total shares||92.2 M|
|Float shares||82.5 M|
|- Institutional holdings (%)||73.9%|
|- Insider holdings (%)||1.1%|
|Shares in short selling||0.0%|
|Friday, May 22nd, 2020|
|Day range||$5.00 - $5.71|
|Average true range||$0.72|
|50d mov avg||$3.73|
|100d mov avg||$4.39|
|200d mov avg||$4.66|
Dynavax performanceStocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. In the following table, we compare Dynavax to :